Reidun Øvstebø, Hans C Dalsbotten Aass, Kari Bente Foss Haug, Anne-Marie Siebke Trøseid, Unni Gopinathan, Peter Kierulf, Jens P Berg, Petter Brandtzaeg, Carola E Henriksson
Index: Innate Immunity 18(4) , 580-91, (2012)
Full Text: HTML
Neisseria meningitidis causes sepsis with coagulopathy. The present study evaluated the tissue factor (TF)-inducing capacity of bacterial LPS in different presentation forms, i.e. membrane-bound LPS versus purified LPS, and of non-LPS components of N. meningitidis. By using a wild-type N. meningitidis, a mutant N. meningitidis lacking LPS (LPS-deficient N. meningitidis), purified LPS from N. meningitidis and Escherichia coli, we measured TF-expression and TF-activity on human monocytes and microparticles (MPs). The effect of TF-modulators, such as phosphatidylserine (PS), tissue factor pathway inhibitor (TFPI) and recombinant IL-10 (rhIL-10) was investigated. In plasmas from meningococcal patients, fibrinopeptide A (FPA), LPS and IL-10 were quantified. Monocytes and MPs exposed to purified LPS or wild-type N. meningitidis had much higher TF-activity than monocytes and MPs exposed to LPS-deficient N. meningitidis (clot formation assay). Incubation with wild-type N. meningitidis, but also LPS-deficient N. meningitidis, resulted in TF-expression on monocytes (flow cytometry, qRT-PCR). Increased cellular TF-activity is associated with coincident surface-exposure of PS and the number of monocytes positive for both PS and TF was significantly higher for monocytes exposed to wild-type N. meningitidis (7.6%) compared with monocytes exposed to LPS-deficient N. meningitidis (1.8%). Treatment with rhIL-10 reduced monocyte- and MP-associated TF-activity, the number of monocytes positive for both TF and PS, and microvesiculation. Patients with meningococcal septicemia had significantly higher levels of LPS, FPA and IL-10 than patients with distinct meningitis. Our results indicate that LPS from N. meningitidis is crucial for inducing TF-activity, but not for monocyte- and MP-associated TF-expression. TF-activity seems to require coincident expression of TF and PS on monocytes, and LPS induces such double-positive monocytes.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Fibrinopeptide A human
CAS:25422-31-5 |
C63H97N19O26 |
Thromboprophylaxis in patients receiving chemotherapy.
2012-05-10 [N. Engl. J. Med. 366(19) , 1839; author reply 1839-40, (2012)] |
Routine heparin for patients with cancer? One answer, more q...
2012-02-16 [N. Engl. J. Med. 366(7) , 661-2, (2012)] |
Congenital dysfibrinogenemia Aα Gly13Glu associated with ble...
2011-03-01 [Thromb. Res. 127(3) , 277-8, (2011)] |
Thrombogenicity of a new injectable biocompatible elastomer ...
2012-06-01 [Eur. J. Vasc. Endovasc. Surg. 43(6) , 675-80, (2012)] |
Novel aspects of fibrin(ogen) fragments during inflammation.
2011-01-01 [Mol. Med. 17(5-6) , 568-73, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved